Active Life Scientific’s Bone Score Device Gets De Novo Approval

Santa Barbara, Calif.-based Active Life Scientific’s Bone Score assessment device has received the FDA’s de novo approval.

The radiation-free assessment uses a novel device called the OsteoProbe to physically measure bone mineral density and structure.

The measurements are quantified on a Bone Material Strength index, providing physicians with information that they can consider when evaluating a patient's bone health.

The Bone Score assessment device earned CE mark certification in 2017.